SCHEMBL27558297

SCHEMBL27558297

c1ncc2ccc(C3CCC3)cc2n1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 9/20 0.50
▸ BACE1 P56817 1/20 0.43
▸ ABL1 P00519 2/20 0.39
▸ CYP11B2 P19099 1/20 0.39
▸ PDGFRB P09619 1/20 0.38
▸ PDGFRA P16234 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ GLA P06280 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ HIF1A Q16665 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ TDO2 P48775 1/20 0.37
▸ PRMT3 O60678 1/20 0.36
▸ PSMB5 P28074 1/20 0.35
▸ HRH3 Q9Y5N1 1/20 0.35
▸ IMPDH2 P12268 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30241134 0.97 EGFR (0.50) EGFRBACE1ABL1CYP11B2PDGFRB
SCHEMBL28110106 0.86 EGFR (0.46) EGFRTDO2HRH3
SCHEMBL22288192 0.71 ALDH1A1 (0.49) BACE1ABL1CYP11B2HTTKMT2A
SCHEMBL8641138 0.70 EGFR (0.64) EGFRKDM4ETDO2IMPDH2
SCHEMBL4971125 0.70 BACE1 (0.50) BACE1ABL1CYP11B2HTTKMT2A
SCHEMBL6992354 0.70 EGFR (0.58) EGFRABL1PDGFRBPDGFRA
SCHEMBL28452949 0.69 BACE1 (0.49) BACE1ABL1CYP11B2HTTSMN1; SMN2
SCHEMBL22777973 0.69 BACE1 (0.49) BACE1ABL1HRH3
SCHEMBL22288360 0.69 BACE1 (0.49) BACE1ABL1CYP11B2PRMT3HRH3
SCHEMBL3823024 0.69 CYP11B2 (0.50) CYP11B2PDGFRBPDGFRAKDM4EGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1356990-A Bicyclic heterocyclic compounds, pharmaceutical compositions containing them, use of the compounds and process for their preparation BOEHRINGER INGELHEIM PHARMA (DE) 2002-07-03 — — CN disclosed
Send feedback